BAP1 loss in uveal melanoma drives selenoproteome dependency and leverages liver selenoprotein P to support metastatic growth
Alyssa Bree Monteleone-Haught
Doctor of Philosophy (Ph.D.), Drexel University
Jul 2026
DOI:
https://doi.org/10.17918/00011516
Files and links (1)
pdf
Monteleone-Haught_Alyssa_202620.69 MB
PDF Embargoed Access, Embargo ends: 31 Aug 2027
Abstract
Cancer Selenoproteomes Uveal melanoma Metastasis
Uveal melanoma (UM) is the most common intraocular malignancy in adults, arising in melanocytes within the uveal tract. Although local disease can be effectively controlled by radiation or enucleation, nearly half of patients ultimately develop fatal liver metastases. Hepatic metastases are strongly associated with loss of the tumor suppressor BAP1, yet the metabolic adaptations that enable BAP1-deficient UM cells to survive and proliferate within the liver remain poorly understood. Transcriptomic analyses revealed that mutant BAP1 UM tumors exhibit elevated expression of genes involved in glutathione (GSH) synthesis. Analysis of human UM cell lines revealed that mutant BAP1 UM cell lines have increased total thiols and an elevated GSH:GSSG ratio, alongside heightened sensitivity to GSH depletion. Given that GSH serves as a cofactor for antioxidant selenoproteins such as GPX4, we investigated the role of selenoproteins in UM liver metastases. We found that mutant BAP1 UM cells exhibited increased dependence on GPX4, as inhibition of GPX4 induced lipid peroxidation and cell death. Because GPX4 requires selenocysteine for its synthesis and activity, we next investigated whether mutant BAP1 UM cells exhibit altered selenium acquisition pathways. Mutant BAP1 UM cells displayed enhanced selenoproteome synthesis and increased utilization of liver-derived selenoprotein P (SEPP) through the receptor LRP8. Moreover, disruption of this BAP1-associated selenoprotein network via LRP8 interference impaired the growth of hepatic lesions and reduced tumor viability in human liver slice models, thereby identifying a potential therapeutic target for metastatic UM. Together, these findings identify a mutant BAP1-associated selenoprotein-dependent vulnerability in metastatic UM.
Metrics
1 Record Views
Details
Title
BAP1 loss in uveal melanoma drives selenoproteome dependency and leverages liver selenoprotein P to support metastatic growth
Creators
Alyssa Bree Monteleone-Haught
Contributors
Edward J. Hartsough (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Philosophy (Ph.D.)
Publisher
Drexel University
Number of pages
xxi, 173 pages
Resource Type
Dissertation
Language
English
Academic Unit
Biochemistry and Molecular Biology; College of Medicine; Drexel University